December 23, 2012 Research and standardization in Alzheimer’s trials: reaching international consensus
December 7, 2012 The National Multiple Sclerosis Society and Critical Path Institute Create the Multiple Sclerosis Outcome Assessments Consortium
November 29, 2012 C-Path Cosponsors Workshop on Combination Drug Development for Alzheimer’s Disease Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches we
November 16, 2012 Assessment of the Most Relevant Symptoms Reported By Patients with Major Depressive Disorder
November 4, 2012 How do Patients Describe Their Depression? – Incorporating the Patient’s Voice into Instrument Development
November 4, 2012 Identifying Disease-Defining Concepts Using Spontaneous and Probed Responses from Semi-Structured Qualitative Interviews in Patients with Major Depressive Disorder
November 3, 2012 Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis (RA): The Role of the Patient-Reported Outcome Consortium’s RA Working Group
November 2, 2012 Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Accelerations Network Dr Carolyn Compton served as planning committee co-chair for the recent Institute of Medicine workshop, “Accelerating the De
